EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+2.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.56B
AUM Growth
+$7.56B
(+1.6%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
165
New
13
Increased
52
Reduced
26
Closed
13
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$59.2M |
| 2 |
FIVE9
FIVN
|
$46.1M |
| 3 |
Xometry
XMTR
|
$42M |
| 4 |
Global E Online
GLBE
|
$34.3M |
| 5 |
Fiverr
FVRR
|
$28.7M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$92.5M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$75.2M |
| 3 |
Celldex Therapeutics
CLDX
|
$53M |
| 4 |
BridgeBio Pharma
BBIO
|
$43.4M |
| 5 |
RingCentral
RNG
|
$33.8M |
Sector Composition
| 1 | Healthcare | 34.45% |
| 2 | Technology | 30.19% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Communication Services | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
BridgeBio Pharma
BBIO
$9.91B
| – | – |
-712,197
| Closed | -$43.4M |
|
152
Equinix
EQIX
$74.6B
| – | – |
-17,693
| Closed | -$14.2M |
|
153
Keros Therapeutics
KROS
$638M
| – | – |
-427,414
| Closed | -$18.2M |
|
154
Lemonade
LMND
$3.68B
| – | – |
-6,000
| Closed | -$480K |
|
155
MSCI
MSCI
$42.7B
| – | – |
-6,500
| Closed | -$3.47M |
|
156
NXP Semiconductors
NXPI
$57.5B
| – | – |
-11,900
| Closed | -$2.45M |
|
157
Sotera Health
SHC
$4.54B
| – | – |
-870,000
| Closed | -$21.1M |
|
158
ARS Pharmaceuticals
SPRY
$1.08B
| – | – |
-371,384
| Closed | -$11.5M |
|
159
Xenon Pharmaceuticals
XENE
$2.99B
| – | – |
-1,490,000
| Closed | -$27.7M |
|
|
AYX
160
DELISTED
Alteryx, Inc.
AYX
| – | – |
-11,000
| Closed | -$1.1M |
|
|
APTO
161
DELISTED
Aptose Biosciences, Inc.
APTO
| – | – |
-5,109
| Closed | -$7.63M |
|
|
MAAC
162
DELISTED
Montes Archimedes Acquisition Corp. Class A Common Stock
MAAC
| – | – |
-700,000
| Closed | -$6.92M |
|